Wells Fargo
WST icon

Wells Fargo’s West Pharmaceutical WST Stock Holding History

Wells Fargo’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,000
Closed -$2.24M – 7397
2025
Q1 		$2.24M Buy
+10,000
New +$2.76M ﹤0.01% 3083
2022
Q1 		– Sell
-100
Closed -$47K – 7925
2021
Q4 		$47K Buy
+100
New +$43K ﹤0.01% 6002

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo's WST Position: Q1 2026 in Review

Wells Fargo reduced its West Pharmaceutical (WST) stake by 9.1% in Q1 2026, selling an estimated $2.42M and leaving 96,974 shares worth $24.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1385.

Wells Fargo first reported a position in WST in Q2 2013 and has held it in 52 quarters since. The position peaked at $165M in Q2 2020. 754 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Wells Fargo held 96,974 shares of West Pharmaceutical worth $24.3M as of Q1 2026.
  • Wells Fargo sold 9,737 West Pharmaceutical shares in Q1 2026, an estimated $2.42M.
  • West Pharmaceutical made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #1385 holding.
  • Wells Fargo first reported a position in West Pharmaceutical in Q2 2013 and has held it in 52 quarters since.
  • Wells Fargo's West Pharmaceutical position peaked at $165M in Q2 2020.
  • 754 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.